Status:
COMPLETED
Neurofeedback Training for the Treatment of Substance Use Disorders
Lead Sponsor:
Sorlandet Hospital HF
Conditions:
Substance Use Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed randomized controlled trial (RCT) will investigate the usefulness of electroencephalographic (EEG) biofeedback, also called neurofeedback (NF), a treatment method that can potentially pre...
Detailed Description
A patient with a substance use disorder (SUD) typically requires comprehensive and individualized care across different levels of service providers, from primary care to the specialist health care ser...
Eligibility Criteria
Inclusion
- Patients with a substance use disorder referred to outpatient addiction treatment, aged \>18 of both genders.
Exclusion
- Severe psychiatric disorders (e.g. psychosis) that have not been stabilized with e.g., medication (assessed as a part of the clinical process at the clinic). Severe cognitive impairment or language problems (inability to converse for interviews).
Key Trial Info
Start Date :
September 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 19 2021
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT03356210
Start Date
September 12 2017
End Date
January 19 2021
Last Update
June 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sorlandet Hospital HF
Kristiansand, Vest Agder, Norway, 4604